Literature DB >> 2946210

Plasma levels of immunoreactive atrial natriuretic factor increase during supraventricular tachycardia.

J M Nicklas, L A DiCarlo, P T Koller, F Morady, E A Diltz, Y Shenker, R J Grekin.   

Abstract

A significant diuretic and natriuretic response occurs during paroxysmal supraventricular tachycardia (SVT). Although the diuresis may be secondary to suppression of vasopressin secretion, the etiology of the natriuresis remains unexplained. To determine if atrial natriuretic factor (ANF) could contribute to the polyuric response during SVT, 10 patients were studied: five during spontaneous SVT and five during simulated SVT produced by rapid simultaneous atrial and ventricular pacing. Plasma immunoreactive ANF (IR-ANF) levels measured by radioimmunoassay were obtained at baseline (before and/or 24 to 48 hours after SVT) and after at least 15 minutes of SVT in all patients. During spontaneous and simulated SVT, IR-ANF was significantly elevated (mean +/- SE; 275 +/- 68 pmol/L) compared to baseline (28 +/- 7 pmol/L; p = 0.0036). Similar increases in IR-ANF were noted during both simulated and spontaneous SVT. To determine if this IR-ANF release was related to the increase in heart rate or the rise in right atrial pressure during SVT, IR-ANF levels were also measured in five patients with sinus tachycardia and in six patients with congestive heart failure. IR-ANF was significantly related to right atrial pressure (r = 0.93; p = 0.0009) but not to heart rate (r = 0.46). Thus, IR-ANF is elevated during SVT and may contribute to the natriuretic response. The stimulus to IR-ANF secretion during SVT appears to be related to the rise in right atrial pressure rather than to the increase in heart rate.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2946210     DOI: 10.1016/0002-8703(86)90301-7

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  7 in total

1.  Raised plasma concentrations of atrial natriuretic peptide are independent of left atrial dimensions in patients with chronic atrial fibrillation.

Authors:  H Berglund; S Boukter; E Theodorsson; H Vallin; O Edhag
Journal:  Br Heart J       Date:  1990-07

Review 2.  Effects of exercise on atrial natriuretic factor. Release mechanisms and implications for fluid homeostasis.

Authors:  B J Freund; C E Wade; J R Claybaugh
Journal:  Sports Med       Date:  1988-12       Impact factor: 11.136

3.  Diagnostic challenges in supraventricular tachycardia: anticipating value of natriuretic peptides.

Authors:  Ertan Yetkin
Journal:  Cardiovasc Endocrinol Metab       Date:  2018-05-16

4.  Perioperative changes in plasma brain natriuretic peptide concentrations in patients undergoing cardiac surgery.

Authors:  K Morimoto; T Mori; S Ishiguro; N Matsuda; Y Hara; H Kuroda
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

5.  Atrial natriuretic factor responses to submaximal and maximal exercise.

Authors:  K Mandroukas; A Zakas; N Aggelopoulou; K Christoulas; G Abatzides; M Karamouzis
Journal:  Br J Sports Med       Date:  1995-12       Impact factor: 13.800

6.  Increasing atrial pressure during cardiac tamponade does not elevate plasma levels of the peptide ANP in conscious dogs.

Authors:  H S Klopfenstein; D W Mathias; G A Bernath; T L Cogswell
Journal:  J Physiol       Date:  1990-02       Impact factor: 5.182

7.  Clinical presentation of paroxysmal supraventricular tachycardia: evaluation of usual and unusual symptoms.

Authors:  Ertan Yetkin; Selcuk Ozturk; Bilal Cuglan; Hasan Turhan
Journal:  Cardiovasc Endocrinol Metab       Date:  2020-05-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.